Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL177P is a pseudogene located in the human genome, representing a truncated or mutated copy of the gene encoding 7SL RNA, a non-coding RNA component of the signal recognition particle (SRP)[1][7]. The **7SL RNA** serves as a scaffold within the SRP, which guides the cotranslational insertion of secretory proteins into the endoplasmic reticulum[5][3]. Unlike the genuine RN7SL1 gene (7SL RNA), RN7SL177P does not produce a functional RNA, nor does it participate directly in protein targeting or cellular signaling[1][7]. Most 7SL pseudogenes, including RN7SL177P, arose via reverse transcription and DNA integration and are not expressed or functional in normal cells[7]. There are currently no established disease roles, clinical relevance, or therapeutic implications for RN7SL177P. If you need information about the actual **functional 7SL RNA (RN7SL1)**, which plays an essential role in SRP-mediated protein targeting and is implicated in certain cancer pathways[5][3], refer to RN7SL1, not RN7SL pseudogenes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 177, pseudogene (RN7SL177P).